Biopharmaceuticals are the future of the pharmaceutical industry. Groundbreaking progress is made every year, and pharmaceuticals tailored for our individual genetic conditions are believed not to be too farfetched.
In the middle of this revolution is the Swedish company Gyros AB, based in Uppsala. Practically every large pharmaceutical that develops and manufactures biopharmaceuticals is already using their so-called immunoassay platform, a system that analyses samples in pre-clinical and clinical trials. And with the introduction of the Gyrolab xPlore, the company has presented a product that lowers the threshold for even more labs around the globe to start using their revolutionary platform in the pursuit of alleviate and cure disease. Read more